Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

72.44
-0.0600-0.08%
Post-market: 72.440.00000.00%19:57 EDT
Volume:1.77M
Turnover:128.04M
Market Cap:14.18B
PE:-20.30
High:74.11
Open:73.23
Low:71.98
Close:72.50
52wk High:93.42
52wk Low:48.78
Shares:195.81M
Float Shares:167.00M
Volume Ratio:0.87
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.64
PE(LYR):-19.14

Loading ...

BridgeBio Pharma Price Target Maintained with a $120.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 10

BridgeBio Highlights $1.7 Billion Cash Position, Targets Three Potential US Launches by Mid-2027

Reuters
·
Sep 09

BridgeBio Posts Propel 3 Phase 3 Infigratinib Data in Children with Achondroplasia Presentation

Reuters
·
Sep 09

BridgeBio Says FDA Reviews NDA for Infigratinib in Achondroplasia

Reuters
·
Sep 09

BridgeBio Pharma Inc: Submitted an Nda to FDA for Oral Infigratinib in Achondroplasia and Anticipates a U.S. Launch in Mid-2027

THOMSON REUTERS
·
Sep 09

Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 Propel 3 Trial

THOMSON REUTERS
·
Sep 09

BridgeBio Pharma, - Oral Infigratinib Shows Favorable Trends Versus Placebo in Sleep Apnea and Otitis Media at 52 Weeks

THOMSON REUTERS
·
Sep 09

BridgeBio Oncology Therapeutics Releases RAS-Pathway Therapeutics Corporate Update Deck

Reuters
·
Sep 09

BridgeBio Pharma (BBIO) Stock Looks Fully Priced Despite Strong Sales Growth

Simply Wall St.
·
Sep 02

BridgeBio Pharma files $500M mixed securities shelf

TIPRANKS
·
Sep 02

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Sep 01

BridgeBio Pharma is Maintained at Outperform by Mizuho

Dow Jones
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

U.S. Stocks on the MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics

Reuters
·
Sep 01

BridgeBio Management Joins Fireside Chats at September Healthcare Investor Conferences

Reuters
·
Sep 01

Mizuho Raises Price Target on BridgeBio Pharma to $110 From $96, Keeps Outperform Rating

MT Newswires Live
·
Sep 01

White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies

MT Newswires Live
·
Sep 01

U.S. Research Roundup-Autodesk, Hubspot, Oracle

Reuters
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

BridgeBio Signs Voluntary Access and Affordability Agreement with US Government

Reuters
·
Sep 01